Skip directly to content

High Eye Pressure & Glaucoma

High Eye Pressure & Glaucoma

Raising awareness about lowering eye pressure

Glaucoma affects millions of Americans, but many don't know they have it. We're committed to helping protect people’s sight by spreading the word about high eye pressure and open-angle glaucoma.

High eye pressure (also known as high intraocular pressure or high IOP) can put you at risk for glaucoma.

  • It occurs when drainage channels in the eye clog, increasing pressure in the eye. This can hurt the optic nerve
  • You can't usually feel high eye pressure, and there often are no symptoms at first. But that doesn't mean that it isn't damaging your sight
  • If the optic nerve becomes damaged from increased eye pressure, you may have glaucoma. And since this damage to your sight can't be fixed, it is important to have regular eye exams—especially if you are at risk

There are many types of glaucoma. But open-angle glaucoma is the most common type. And while open-angle glaucoma is linked to increased pressure inside the eye, not all patients with glaucoma have high eye pressure. That means:

  • Your eye pressure may be normal and you would still be at risk for glaucoma
  • You may have some type of glaucoma that doesn’t respond to eye pressure–lowering treatments

See your doctor to determine what type of glaucoma you have and if it is related to high eye pressure.

 
XALATAN® (latanoprost ophthalmic solution) Savings Card
Find out how you may start saving today on your brand-name XALATAN prescription.
Learn more
 
Keep Track of Your Progress
Learn how to administer XALATAN drops and track your eye pressure during treatment.
Download the guide

Important Safety Information

XALATAN® (latanoprost ophthalmic solution) is not recommended in patients with a known hypersensitivity to latanoprost, benzalkonium chloride, or any other ingredients in this product.

XALATAN may slowly cause darkening of the eye color, darkening of the eyelid and eyelashes, and increased growth and thickness of eyelashes. Color changes may increase as long as XALATAN is administered, and eye color changes are likely to be permanent.

There have been reports of bacterial keratitis associated with the use of multiple-dose containers of topical ophthalmic products.

Contact lenses should be removed prior to the administration of XALATAN. Contact lenses can be reinserted 15 minutes following administration of XALATAN.

The most common side effects for XALATAN may include blurred vision, burning and stinging, eye redness, eye itching, the feeling of something in the eye, increased darkening of eye color, irritation of the clear front surface of the eye, or cold or flu.

Indication

XALATAN is a prescription medication for the treatment of high eye pressure/intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.

Patients should always ask their doctors for medical advice about adverse events.

You may report an adverse event related to Pfizer products by calling 1-800-438-1985 (US only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. The FDA has established a reporting service known as MedWatch where health care professionals and consumers can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit MedWatch or call 1-800-FDA-1088.

*Terms and Conditions

By participating in the XALATAN Savings Card Program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

  • The Card is not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare, or other federal or state healthcare programs, including any state prescription drug assistance programs and the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma de Salud”)
  • The Card is not valid for prescriptions that are eligible to be reimbursed by private insurance plans or other health or pharmacy benefit programs, which reimburse you for the entire cost of your prescription drugs
  • Patients must be 18 or older
  • You must deduct the savings received under this program from any reimbursement request submitted to your insurance plan, either directly by you or on your behalf
  • By using the Card, eligible patients may receive a savings of up to $125 per fill off their monthly out-of-pocket costs on quantities of 7.49 mL and below. The Card is good for a maximum savings of $1,500 per year ($125 per month x 12 months). Thus, if your out-of-pocket cost is more than $125, you will save $125 off of your total out-of-pocket costs. [Example: If your out-of-pocket cost is $150, you will pay $25 ($150-$125 = $25).] If your out-of-pocket cost is $125 or less, your out-of-pocket cost is $0. For a mail-order 3-month prescription (quantities greater than 7.50 mL), your total maximum savings may be $375 ($125 x 3)
  • The Card is not valid for Massachusetts residents whose prescriptions are covered, in whole or in part, by third-party insurance, or where otherwise prohibited by law
  • The Card cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription
  • The Card will be accepted only at participating pharmacies
  • The Card is not health insurance
  • This offer is good only in the U.S. and Puerto Rico
  • The Card is limited to one per person during this offering period and is not transferable
  • Pfizer reserves the right to rescind, revoke, or amend this offer without notice at any time
  • No membership fees. The Card and Program expire on 12/31/17

For help with the XALATAN Savings Card Program, call 1-866-562-6147, or write: XALATAN Savings Program, 14001 Weston Parkway, Suite 103, Cary, NC 27513. Be sure to include your name and mailing address.

You are leaving XALATAN.com

You are leaving this website. Links to all outside websites are provided as a convenience to our visitors and do not imply an endorsement or recommendation by Pfizer. Pfizer accepts no responsibility or liability for the content or services of other websites.